PI3K signalling in inflammation

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1851, Issue 6, 2015, Pages 882-897

  Hawkins, P T ^a   Stephens, L R ^a  

^a BABRAHAM INSTITUTE   (United Kingdom)

Author keywords

Inflammation; PI3K

Indexed keywords

ENZYME INHIBITOR; ISOENZYME; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLINOSITOL 3 KINASE;

ANIMAL; ANTAGONISTS AND INHIBITORS; AUTOPHAGY; CHEMISTRY; DRUG EFFECTS; ENDOSOME; GENE EXPRESSION REGULATION; GENETICS; HUMAN; INFLAMMATION; INNATE IMMUNITY; METABOLISM; MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; AUTOPHAGY; BIOLOGICAL TRANSPORT; ENDOSOMES; ENZYME INHIBITORS; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; ISOENZYMES; MICE; MICE, TRANSGENIC; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHATIDYLINOSITOLS; SIGNAL TRANSDUCTION;

EID: 84935923752     PISSN: 13881981     EISSN: 18792618     Source Type: Journal    
DOI: 10.1016/j.bbalip.2014.12.006     Document Type: Review

References (237)

1. A. Ghigo, F. Damilano, L. Braccini, and E. Hirsch PI3K inhibition in inflammation: Toward tailored therapies for specific diseases Bioessays 32 2010 185 196
2. E. Banham-Hall, M.R. Clatworthy, and K. Okkenhaug The therapeutic potential for PI3K inhibitors in autoimmune rheumatic diseases Open Rheumatol. J. 6 2012 245 258
3. K. Okkenhaug Signaling by the phosphoinositide 3-kinase family in immune cells Annu. Rev. Immunol. 31 2013 675 704
4. J.G. Foster, M.D. Blunt, E. Carter, and S.G. Ward Inhibition of PI3K signaling spurs new therapeutic opportunities in inflammatory/autoimmune diseases and hematological malignancies Pharmacol. Rev. 64 2012 1027 1054
5. L. So, and D.A. Fruman PI3K signalling in B- and T-lymphocytes: New developments and therapeutic advances Biochem. J. 442 2012 465 481
6. C. Nathan Points of control in inflammation Nature 420 2002 846 852
7. C. Nathan, and A. Ding Nonresolving inflammation Cell 140 2010 871 882
8. M. Karin, T. Lawrence, and V. Nizet Innate immunity gone awry: linking microbial infections to chronic inflammation and cancer Cell 124 2006 823 835
9. R. Medzhitov Origin and physiological roles of inflammation Nature 454 2008 428 435
10. H. Spits, D. Artis, M. Colonna, A. Diefenbach, and J.P. Di Santo et al. Innate lymphoid cells - a proposal for uniform nomenclature Nat. Rev. Immunol. 13 2013 145 149
11. M. Phillipson, and P. Kubes The neutrophil in vascular inflammation Nat. Med. 17 2011 1381 1390
12. M.A. Shelef, S. Tauzin, and A. Huttenlocher Neutrophil migration: moving from zebrafish models to human autoimmunity Immunol. Rev. 256 2013 269 281
13. K. Newton, and V.M. Dixit Signaling in innate immunity and inflammation Cold Spring Harb. Perspect. Biol. 4 2012
14. E. Kolaczkowska, and P. Kubes Neutrophil recruitment and function in health and inflammation Nat. Rev. Immunol. 13 2013 159 175
15. K. Ley, C. Laudanna, M.I. Cybulsky, and S. Nourshargh Getting to the site of inflammation: The leukocyte adhesion cascade updated Nat. Rev. Immunol. 7 2007 678 689
16. C.N. Morrell, A.A. Aggrey, L.M. Chapman, and K.L. Modjeski Emerging roles for platelets as immune and inflammatory cells Blood 123 2014 2759 2767
17. R.R. Hardy, P.W. Kincade, and K. Dorshkind The protean nature of cells in the B lymphocyte lineage Immunity 26 2007 703 714
18. C. Linnemann, R. Mezzadra, and T.N. Schumacher TCR repertoires of intratumoral T-cell subsets Immunol. Rev. 257 2014 72 82
19. A. Singer, S. Adoro, and J.H. Park Lineage fate and intense debate: myths, models and mechanisms of CD4- versus CD8-lineage choice Nat. Rev. Immunol. 8 2008 788 801
20. J. Neefjes, M.L. Jongsma, P. Paul, and O. Bakke Towards a systems understanding of MHC class I and MHC class II antigen presentation Nat. Rev. Immunol. 11 2011 823 836
21. J.M. Vyas, A.G. Van der Veen, and H.L. Ploegh The known unknowns of antigen processing and presentation Nat. Rev. Immunol. 8 2008 607 618
22. K.M. Murphy, and B. Stockinger Effector T cell plasticity: flexibility in the face of changing circumstances Nat. Immunol. 11 2010 674 680
23. P. Kidd Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease Altern. Med. Rev. 8 2003 223 246
24. G.D. Victora, and M.C. Nussenzweig Germinal centers Annu. Rev. Immunol. 30 2012 429 457
25. K. Hirota, H. Ahlfors, J.H. Duarte, and B. Stockinger Regulation and function of innate and adaptive interleukin-17-producing cells EMBO Rep. 13 2012 113 120
26. M. Barry, and R.C. Bleackley Cytotoxic T lymphocytes: all roads lead to death Nat. Rev. Immunol. 2 2002 401 409
27. S.A. Oracki, J.A. Walker, M.L. Hibbs, L.M. Corcoran, and D.M. Tarlinton Plasma cell development and survival Immunol. Rev. 237 2010 140 159
28. N. Schmitt, S.E. Bentebibel, and H. Ueno Phenotype and functions of memory Tfh cells in human blood Trends Immunol. 35 2014 436 442
29. N.D. Bushar, and D.L. Farber Recalling the year in memory T cells Ann. N. Y. Acad. Sci. 1143 2008 212 225
30. S.C. Bischoff Role of mast cells in allergic and non-allergic immune responses: comparison of human and murine data Nat. Rev. Immunol. 7 2007 93 104
31. H. Karasuyama, K. Mukai, Y. Tsujimura, and K. Obata Newly discovered roles for basophils: a neglected minority gains new respect Nat. Rev. Immunol. 9 2009 9 13
32. Y. Bordon Allergy: shocking behaviour Nat. Rev. Immunol. 11 2011 302 303
33. H. von Boehmer, and F. Melchers Checkpoints in lymphocyte development and autoimmune disease Nat. Immunol. 11 2010 14 20
34. S.Z. Josefowicz, and A. Rudensky Control of regulatory T cell lineage commitment and maintenance Immunity 30 2009 616 625
35. E.C. Rosser, P.A. Blair, and C. Mauri Cellular targets of regulatory B cell-mediated suppression Mol. Immunol. 62 2014 296 304
36. S. Nagaraj, J.I. Youn, and D.I. Gabrilovich Reciprocal relationship between myeloid-derived suppressor cells and T cells J. Immunol. 191 2013 17 23
37. E. Rai, and E.K. Wakeland Genetic predisposition to autoimmunity - what have we learned? Semin. Immunol. 23 2011 67 83
38. J. Ermann, and C.G. Fathman Autoimmune diseases: genes, bugs and failed regulation Nat. Immunol. 2 2001 759 761
39. B. Vanhaesebroeck, J. Guillermet-Guibert, M. Graupera, and B. Bilanges The emerging mechanisms of isoform-specific PI3K signalling Nat. Rev. Mol. Cell Biol. 11 2010 329 341
40. P.T. Hawkins, K.E. Anderson, K. Davidson, and L.R. Stephens Signalling through Class I PI3Ks in mammalian cells Biochem. Soc. Trans. 34 2006 647 662
41. M.A. Lemmon Membrane recognition by phospholipid-binding domains Nat. Rev. Mol. Cell Biol. 9 2008 99 111
42. M.S. Song, L. Salmena, and P.P. Pandolfi The functions and regulation of the PTEN tumour suppressor Nat. Rev. Mol. Cell Biol. 13 2012 283 296
43. M.J. Hamilton, V.W. Ho, E. Kuroda, J. Ruschmann, and F. Antignano et al. Role of SHIP in cancer Exp. Hematol. 39 2011 2 13
44. D. Blero, B. Payrastre, S. Schurmans, and C. Erneux Phosphoinositide phosphatases in a network of signalling reactions Pflugers Arch. 455 2007 31 44
45. M. Huber, and B.F. Gibbs SHIP1 and the negative control of mast cell/basophil activation by supra-optimal antigen concentrations Mol. Immunol. 63 2015 32 37
46. J.M. Dyson, C.G. Fedele, E.M. Davies, J. Becanovic, and C.A. Mitchell Phosphoinositide phosphatases: just as important as the kinases Subcell. Biochem. 58 2012 215 279
47. L.R. Stephens, K.T. Hughes, and R.F. Irvine Pathway of phosphatidylinositol(3,4,5)-trisphosphate synthesis in activated neutrophils Nature 351 1991 33 39
48. S. Krugmann, K.E. Anderson, S.H. Ridley, N. Risso, and A. McGregor et al. Identification of ARAP3, a novel PI3K effector regulating both Arf and Rho GTPases, by selective capture on phosphoinositide affinity matrices Mol. Cell 9 2002 95 108
49. A. Allam, and A.J. Marshall Role of the adaptor proteins Bam32, TAPP1 and TAPP2 in lymphocyte activation Immunol. Lett. 97 2005 7 17
50. M.D. Blunt, and S.G. Ward Targeting PI3K isoforms and SHIP in the immune system: new therapeutics for inflammation and leukemia Curr. Opin. Pharmacol. 12 2012 444 451
51. B.D. Manning, and L.C. Cantley AKT/PKB signaling: navigating downstream Cell 129 2007 1261 1274
52. J.A. Engelman, J. Luo, and L.C. Cantley The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism Nat. Rev. Genet. 7 2006 606 619
53. D.K. Finlay mTORC1 regulates CD8 + T-cell glucose metabolism and function independently of PI3K and PKB Biochem. Soc. Trans. 41 2013 681 686
54. K.U. Birkenkamp, and P.J. Coffer FOXO transcription factors as regulators of immune homeostasis: molecules to die for? J. Immunol. 171 2003 1623 1629
55. J.M. Bradshaw The Src, Syk, and Tec family kinases: distinct types of molecular switches Cell. Signal. 22 2010 1175 1184
56. Q. Deng, and A. Huttenlocher Leukocyte migration from a fish eye's view J. Cell Sci. 125 2012 3949 3956
57. L. Stephens, L. Milne, and P. Hawkins Moving towards a better understanding of chemotaxis Curr. Biol. 18 2008 R485 R494
58. Y. Mazaki, Y. Nishimura, and H. Sabe GBF1 bears a novel phosphatidylinositol-phosphate binding module, BP3K, to link PI3Kgamma activity with Arf1 activation involved in GPCR-mediated neutrophil chemotaxis and superoxide production Mol. Biol. Cell 23 2012 2457 2467
59. R. Fritsch, and J. Downward SnapShot: Class I PI3K isoform signaling Cell 154 2013 940-940.e1
60. O. Vadas, J.E. Burke, X. Zhang, A. Berndt, and R.L. Williams Structural basis for activation and inhibition of class I phosphoinositide 3-kinases Sci. Signal. 4 2011 re2
61. C. Costa, E.L. Martin-Conte, and E. Hirsch Phosphoinositide 3-kinase p110gamma in immunity IUBMB Life 63 2011 707 713
62. S. Suire, A.M. Condliffe, G.J. Ferguson, C.D. Ellson, and H. Guillou et al. Gbetagammas and the Ras binding domain of p110gamma are both important regulators of PI(3)Kgamma signalling in neutrophils Nat. Cell Biol. 8 2006 1303 1309
63. T. Bohnacker, R. Marone, E. Collmann, R. Calvez, and E. Hirsch et al. PI3Kgamma adaptor subunits define coupling to degranulation and cell motility by distinct PtdIns(3,4,5)P3 pools in mast cells Sci. Signal. 2 2009 ra27
64. B. Kurig, A. Shymanets, T. Bohnacker, and Brock C. Prajwal et al. Ras is an indispensable coregulator of the class IB phosphoinositide 3-kinase p87/p110gamma Proc. Natl. Acad. Sci. U. S. A. 106 2009 20312 20317
65. S. Suire, J. Coadwell, G.J. Ferguson, K. Davidson, and P. Hawkins et al. p84, a new Gbetagamma-activated regulatory subunit of the type IB phosphoinositide 3-kinase p110gamma Curr. Biol. 15 2005 566 570
66. R. Walser, J.E. Burke, E. Gogvadze, T. Bohnacker, and X. Zhang et al. PKCbeta phosphorylates PI3Kgamma to activate it and release it from GPCR control PLoS Biol. 11 2013 e1001587
67. R. Fritsch, I. de Krijger, K. Fritsch, R. George, and B. Reason et al. RAS and RHO families of GTPases directly regulate distinct phosphoinositide 3-kinase isoforms Cell 153 2013 1050 1063
68. J.M. Backer The regulation of class IA PI 3-kinases by inter-subunit interactions Curr. Top. Microbiol. Immunol. 346 2010 87 114
69. O. Vadas, H.A. Dbouk, A. Shymanets, O. Perisic, and J.E. Burke et al. Molecular determinants of PI3Kgamma-mediated activation downstream of G-protein-coupled receptors (GPCRs) Proc. Natl. Acad. Sci. U. S. A. 110 2013 18862 18867
70. H.A. Dbouk, O. Vadas, A. Shymanets, J.E. Burke, and R.S. Salamon et al. G protein-coupled receptor-mediated activation of p110beta by Gbetagamma is required for cellular transformation and invasiveness Sci. Signal. 5 2012 ra89
71. Z. Dou, J.A. Pan, H.A. Dbouk, L.M. Ballou, and J.L. DeLeon et al. Class IA PI3K p110beta subunit promotes autophagy through Rab5 small GTPase in response to growth factor limitation Mol. Cell 50 2013 29 42
72. L. So, S.S. Yea, J.S. Oak, M. Lu, and A. Manmadhan et al. Selective inhibition of phosphoinositide 3-kinase p110alpha preserves lymphocyte function J. Biol. Chem. 288 2013 5718 5731
73. J.K. Juss, R.P. Hayhoe, C.E. Owen, I. Bruce, and S.R. Walmsley et al. Functional redundancy of class I phosphoinositide 3-kinase (PI3K) isoforms in signaling growth factor-mediated human neutrophil survival PLoS ONE 7 2012 e45933
74. G. Takayama, M. Ohtani, A. Minowa, S. Matsuda, and S. Koyasu Class I PI3K-mediated Akt and ERK signals play a critical role in FcepsilonRI-induced degranulation in mast cells Int. Immunol. 25 2013 215 220
75. A.M. Condliffe, K. Davidson, K.E. Anderson, C.D. Ellson, and T. Crabbe et al. Sequential activation of class IB and class IA PI3K is important for the primed respiratory burst of human but not murine neutrophils Blood 106 2005 1432 1440
76. S. Kulkarni, C. Sitaru, Z. Jakus, K.E. Anderson, and G. Damoulakis et al. PI3Kbeta plays a critical role in neutrophil activation by immune complexes Sci. Signal. 4 2011 ra23
77. M. Laffargue, R. Calvez, P. Finan, A. Trifilieff, and M. Barbier et al. Phosphoinositide 3-kinase gamma is an essential amplifier of mast cell function Immunity 16 2002 441 451
78. K.O. Schink, C. Raiborg, and H. Stenmark Phosphatidylinositol 3-phosphate, a lipid that regulates membrane dynamics, protein sorting and cell signalling Bioessays 35 2013 900 912
79. J.M. Backer The regulation and function of Class III PI3Ks: novel roles for Vps34 Biochem. J. 410 2008 1 17
80. F. O' Farrell, T.E. Rusten, and H. Stenmark Phosphoinositide 3-kinases as accelerators and brakes of autophagy FEBS J. 280 2013 6322 6337
81. R. Roberts, and N.T. Ktistakis Omegasomes: PI3P platforms that manufacture autophagosomes Essays Biochem. 55 2013 17 27
82. J. Kim, Y.C. Kim, C. Fang, R.C. Russell, and J.H. Kim et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy Cell 152 2013 290 303
83. M. Falasca, and T. Maffucci Regulation and cellular functions of class II phosphoinositide 3-kinases Biochem. J. 443 2012 587 601
84. K. Yoshioka, K. Yoshida, H. Cui, T. Wakayama, and N. Takuwa et al. Endothelial PI3K-C2alpha, a class II PI3K, has an essential role in angiogenesis and vascular barrier function Nat. Med. 18 2012 1560 1569
85. I. Franco, F. Gulluni, C.C. Campa, C. Costa, and J.P. Margaria et al. PI3K class II alpha controls spatially restricted endosomal PtdIns3P and Rab11 activation to promote primary cilium function Dev. Cell 28 2014 647 658
86. Y. Posor, M. Eichhorn-Gruenig, D. Puchkov, J. Schoneberg, and A. Ullrich et al. Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate Nature 499 2013 233 237
87. T.D. Cushing, D.P. Metz, D.A. Whittington, and L.R. McGee PI3Kdelta and PI3Kgamma as targets for autoimmune and inflammatory diseases J. Med. Chem. 55 2012 8559 8581
88. E. Hirsch, V.L. Katanaev, C. Garlanda, O. Azzolino, and L. Pirola et al. Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation Science 287 2000 1049 1053
89. Z. Li, H. Jiang, W. Xie, Z. Zhang, and A.V. Smrcka et al. Roles of PLC-beta2 and -beta3 and PI3Kgamma in chemoattractant-mediated signal transduction Science 287 2000 1046 1049
90. T. Sasaki, J. Irie-Sasaki, R.G. Jones, A.J. Oliveira-dos-Santos, and W.L. Stanford et al. Function of PI3Kgamma in thymocyte development, T cell activation, and neutrophil migration Science 287 2000 1040 1046
91. E. Clayton, G. Bardi, S.E. Bell, D. Chantry, and C.P. Downes et al. A crucial role for the p110delta subunit of phosphatidylinositol 3-kinase in B cell development and activation J. Exp. Med. 196 2002 753 763
92. K. Okkenhaug, A. Bilancio, G. Farjot, H. Priddle, and S. Sancho et al. Impaired B and T cell antigen receptor signaling in p110delta PI 3-kinase mutant mice Science 297 2002 1031 1034
93. X. Zhou, J. Takatoh, and F. Wang The mammalian class 3 PI3K (PIK3C3) is required for early embryogenesis and cell proliferation PLoS ONE 6 2011 e16358
94. R. Bago, N. Malik, M.J. Munson, A.R. Prescott, and P. Davies et al. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase Biochem. J. 463 2014 413 427
95. B. Ronan, O. Flamand, L. Vescovi, C. Dureuil, and L. Durand et al. A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy Nat. Chem. Biol. 10 2014 1013 1019
96. D.P. Harris, P. Vogel, M. Wims, K. Moberg, and J. Humphries et al. Requirement for class II phosphoinositide 3-kinase C2alpha in maintenance of glomerular structure and function Mol. Cell. Biol. 31 2011 63 80
97. K. Harada, A.B. Truong, T. Cai, and P.A. Khavari The class II phosphoinositide 3-kinase C2beta is not essential for epidermal differentiation Mol. Cell. Biol. 25 2005 11122 11130
98. G.J. Ferguson, L. Milne, S. Kulkarni, T. Sasaki, and S. Walker et al. PI(3)Kgamma has an important context-dependent role in neutrophil chemokinesis Nat. Cell Biol. 9 2007 86 91
99. D.F. Smith, T.L. Deem, A.C. Bruce, J. Reutershan, and D. Wu et al. Leukocyte phosphoinositide-3 kinase {gamma} is required for chemokine-induced, sustained adhesion under flow in vivo J. Leukoc. Biol. 80 2006 1491 1499
100. L. Barberis, C. Pasquali, D. Bertschy-Meier, A. Cuccurullo, and C. Costa et al. Leukocyte transmigration is modulated by chemokine-mediated PI3Kgamma-dependent phosphorylation of vimentin Eur. J. Immunol. 39 2009 1136 1146
101. D.H. Lim, J.Y. Cho, D.J. Song, S.Y. Lee, and M. Miller et al. PI3K gamma-deficient mice have reduced levels of allergen-induced eosinophilic inflammation and airway remodeling Am. J. Physiol. Lung Cell. Mol. Physiol. 296 2009 L210 L219
102. G.E. Jones, E. Prigmore, R. Calvez, C. Hogan, and G.A. Dunn et al. Requirement for PI 3-kinase gamma in macrophage migration to MCP-1 and CSF-1 Exp. Cell Res. 290 2003 120 131
103. C. Sadhu, B. Masinovsky, K. Dick, C.G. Sowell, and D.E. Staunton Essential role of phosphoinositide 3-kinase delta in neutrophil directional movement J. Immunol. 170 2003 2647 2654
104. K.D. Puri, T.A. Doggett, J. Douangpanya, Y. Hou, and W.T. Tino et al. Mechanisms and implications of phosphoinositide 3-kinase delta in promoting neutrophil trafficking into inflamed tissue Blood 103 2004 3448 3456
105. K.D. Puri, T.A. Doggett, C.Y. Huang, J. Douangpanya, and J.S. Hayflick et al. The role of endothelial PI3Kgamma activity in neutrophil trafficking Blood 106 2005 150 157
106. E. Sapey, J.A. Stockley, H. Greenwood, A. Ahmad, and D. Bayley et al. Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 183 2011 1176 1186
107. R. Shimizu-Hirota, W. Xiong, B.T. Baxter, S.L. Kunkel, and I. Maillard et al. MT1-MMP regulates the PI3Kdelta.Mi-2/NuRD-dependent control of macrophage immune function Genes Dev. 26 2012 395 413
108. Y. Leverrier, K. Okkenhaug, C. Sawyer, A. Bilancio, and B. Vanhaesebroeck et al. Class I phosphoinositide 3-kinase p110beta is required for apoptotic cell and Fcgamma receptor-mediated phagocytosis by macrophages J. Biol. Chem. 278 2003 38437 38442
109. K.B. Boyle, D. Gyori, A. Sindrilaru, K. Scharffetter-Kochanek, and P.R. Taylor et al. Class IA phosphoinositide 3-kinase beta and delta regulate neutrophil oxidase activation in response to Aspergillus fumigatus hyphae J. Immunol. 186 2011 2978 2989
110. A. Mocsai, J. Ruland, and V.L. Tybulewicz The SYK tyrosine kinase: a crucial player in diverse biological functions Nat. Rev. Immunol. 10 2010 387 402
111. P. Beemiller, Y. Zhang, S. Mohan, E. Levinsohn, and I. Gaeta et al. A Cdc42 activation cycle coordinated by PI 3-kinase during Fc receptor-mediated phagocytosis Mol. Biol. Cell 21 2010 470 480
112. D. Cox, C.C. Tseng, G. Bjekic, and S. Greenberg A requirement for phosphatidylinositol 3-kinase in pseudopod extension J. Biol. Chem. 274 1999 1240 1247
113. K.E. Anderson, K.B. Boyle, K. Davidson, T.A. Chessa, and S. Kulkarni et al. CD18-dependent activation of the neutrophil NADPH oxidase during phagocytosis of Escherichia coli or Staphylococcus aureus is regulated by class III but not class I or II PI3Ks Blood 112 2008 5202 5211
114. P.T. Hawkins, L.R. Stephens, S. Suire, and M. Wilson PI3K signaling in neutrophils Curr. Top. Microbiol. Immunol. 346 2010 183 202
115. J.D. Chang, G.K. Sukhova, P. Libby, E. Schvartz, and A.H. Lichtenstein et al. Deletion of the phosphoinositide 3-kinase p110gamma gene attenuates murine atherosclerosis Proc. Natl. Acad. Sci. U. S. A. 104 2007 8077 8082
116. J. Guillermet-Guibert, K. Bjorklof, A. Salpekar, C. Gonella, and F. Ramadani et al. The p110beta isoform of phosphoinositide 3-kinase signals downstream of G protein-coupled receptors and is functionally redundant with p110gamma Proc. Natl. Acad. Sci. U. S. A. 105 2008 8292 8297
117. J.A. Swanson Shaping cups into phagosomes and macropinosomes Nat. Rev. Mol. Cell Biol. 9 2008 639 649
118. T.D. Troutman, J.F. Bazan, and C. Pasare Toll-like receptors, signaling adapters and regulation of the pro-inflammatory response by PI3K Cell Cycle 11 2012 3559 3567
119. E. Aksoy, S. Taboubi, D. Torres, S. Delbauve, and A. Hachani et al. The p110delta isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock Nat. Immunol. 13 2012 1045 1054
120. A. Del Prete, W. Vermi, E. Dander, K. Otero, and L. Barberis et al. Defective dendritic cell migration and activation of adaptive immunity in PI3Kgamma-deficient mice EMBO J. 23 2004 3505 3515
121. I. Comerford, W. Litchfield, E. Kara, and S.R. McColl PI3Kgamma drives priming and survival of autoreactive CD4(+) T cells during experimental autoimmune encephalomyelitis PLoS ONE 7 2012 e45095
122. A.M. Condliffe, P.T. Hawkins, L.R. Stephens, C. Haslett, and E.R. Chilvers Priming of human neutrophil superoxide generation by tumour necrosis factor-alpha is signalled by enhanced phosphatidylinositol 3,4,5-trisphosphate but not inositol 1,4,5-trisphosphate accumulation FEBS Lett. 439 1998 147 151
123. K. Ali, M. Camps, W.P. Pearce, H. Ji, and T. Ruckle et al. Isoform-specific functions of phosphoinositide 3-kinases: p110 delta but not p110 gamma promotes optimal allergic responses in vivo J. Immunol. 180 2008 2538 2544
124. H. Gu, K. Saito, L.D. Klaman, J. Shen, and T. Fleming et al. Essential role for Gab2 in the allergic response Nature 412 2001 186 190
125. E. Collmann, T. Bohnacker, R. Marone, J. Dawson, and M. Rehberg et al. Transient targeting of phosphoinositide 3-kinase acts as a roadblock in mast cells' route to allergy J. Allergy Clin. Immunol. 132 2013 959 968
126. J. Doukas, L. Eide, K. Stebbins, A. Racanelli-Layton, and L. Dellamary et al. Aerosolized phosphoinositide 3-kinase gamma/delta inhibitor TG100-115 [3-[2,4-diamino-6-(3-hydroxyphenyl)pteridin-7-yl]phenol] as a therapeutic candidate for asthma and chronic obstructive pulmonary disease J. Pharmacol. Exp. Ther. 328 2009 758 765
127. B.F. Nashed, T. Zhang, M. Al-Alwan, G. Srinivasan, and A.J. Halayko et al. Role of the phosphoinositide 3-kinase p110delta in generation of type 2 cytokine responses and allergic airway inflammation Eur. J. Immunol. 37 2007 416 424
128. S.J. Park, K.S. Lee, S.R. Kim, K.H. Min, and H. Moon et al. Phosphoinositide 3-kinase delta inhibitor suppresses interleukin-17 expression in a murine asthma model Eur. Respir. J. 36 2010 1448 1459
129. M. Takeda, W. Ito, M. Tanabe, S. Ueki, and H. Kato et al. Allergic airway hyperresponsiveness, inflammation, and remodeling do not develop in phosphoinositide 3-kinase gamma-deficient mice J. Allergy Clin. Immunol. 123 2009 805 812
130. N. Kim, A. Saudemont, L. Webb, M. Camps, and T. Ruckle et al. The p110delta catalytic isoform of PI3K is a key player in NK-cell development and cytokine secretion Blood 110 2007 3202 3208
131. W.G. Kerr, and F. Colucci Inositol phospholipid signaling and the biology of natural killer cells J. Innate Immun. 3 2011 249 257
132. G. Krystal Lipid phosphatases in the immune system Semin. Immunol. 12 2000 397 403
133. J. Ruschmann, F. Antignano, V. Lam, K. Snyder, and C. Kim et al. The role of SHIP in the development and activation of mouse mucosal and connective tissue mast cells J. Immunol. 188 2012 3839 3850
134. M.J. Rauh, J. Kalesnikoff, M. Hughes, L. Sly, and V. Lam et al. Role of Src homology 2-containing-inositol 5'-phosphatase (SHIP) in mast cells and macrophages Biochem. Soc. Trans. 31 2003 286 291
135. M. Nishio, K. Watanabe, J. Sasaki, C. Taya, and S. Takasuga et al. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1 Nat. Cell Biol. 9 2007 36 44
136. A. Prasad, Y. Jia, A. Chakraborty, Y. Li, and S.K. Jain et al. Inositol hexakisphosphate kinase 1 regulates neutrophil function in innate immunity by inhibiting phosphatidylinositol-(3,4,5)-trisphosphate signaling Nat. Immunol. 12 2011 752 760
137. M. Bohdanowicz, and S. Grinstein Role of phospholipids in endocytosis, phagocytosis, and macropinocytosis Physiol. Rev. 93 2013 69 106
138. O.V. Vieira, R.J. Botelho, L. Rameh, S.M. Brachmann, and T. Matsuo et al. Distinct roles of class I and class III phosphatidylinositol 3-kinases in phagosome formation and maturation J. Cell Biol. 155 2001 19 25
139. C.D. Ellson, K.E. Anderson, G. Morgan, E.R. Chilvers, and P. Lipp et al. Phosphatidylinositol 3-phosphate is generated in phagosomal membranes Curr. Biol. 11 2001 1631 1635
140. S.B. Berger, X. Romero, C. Ma, G. Wang, and W.A. Faubion et al. SLAM is a microbial sensor that regulates bacterial phagosome functions in macrophages Nat. Immunol. 11 2010 920 927
141. O.V. Vieira, R.J. Botelho, and S. Grinstein Phagosome maturation: aging gracefully Biochem. J. 366 2002 689 704
142. C.I. Suh, N.D. Stull, X.J. Li, W. Tian, and M.O. Price et al. The phosphoinositide-binding protein p40phox activates the NADPH oxidase during FcgammaIIA receptor-induced phagocytosis J. Exp. Med. 203 2006 1915 1925
143. C.D. Ellson, K. Davidson, G.J. Ferguson, R. O'Connor, and L.R. Stephens et al. Neutrophils from p40phox -/- mice exhibit severe defects in NADPH oxidase regulation and oxidant-dependent bacterial killing J. Exp. Med. 203 2006 1927 1937
144. M.C. Dinauer Chronic granulomatous disease and other disorders of phagocyte function Hematology Am. Soc. Hematol. Educ. Program 2005 89 95
145. E.R. Allan, P. Tailor, D.R. Balce, P. Pirzadeh, and N.T. McKenna et al. NADPH oxidase modifies patterns of MHC class II-restricted epitopic repertoires through redox control of antigen processing J. Immunol. 192 2014 4989 5001
146. A. Savina, C. Jancic, S. Hugues, P. Guermonprez, and P. Vargas et al. NOX2 controls phagosomal pH to regulate antigen processing during crosspresentation by dendritic cells Cell 126 2006 205 218
147. C. Ellson, K. Davidson, K. Anderson, L.R. Stephens, and P.T. Hawkins PtdIns3P binding to the PX domain of p40phox is a physiological signal in NADPH oxidase activation EMBO J. 25 2006 4468 4478
148. J.D. Matute, A.A. Arias, N.A. Wright, I. Wrobel, and C.C. Waterhouse et al. A new genetic subgroup of chronic granulomatous disease with autosomal recessive mutations in p40 phox and selective defects in neutrophil NADPH oxidase activity Blood 114 2009 3309 3315
149. X. Xu, K. Araki, S. Li, J.H. Han, and L. Ye et al. Autophagy is essential for effector CD8(+) T cell survival and memory formation Nat. Immunol. 15 2014 1152 1161
150. K.B. Boyle, and F. Randow The role of 'eat-me' signals and autophagy cargo receptors in innate immunity Curr. Opin. Microbiol. 16 2013 339 348
151. B. Levine, N. Mizushima, and H.W. Virgin Autophagy in immunity and inflammation Nature 469 2011 323 335
152. B. Yordy, and A. Iwasaki Autophagy in the control and pathogenesis of viral infection Curr. Opin. Virol. 1 2011 196 203
153. C. Munz Enhancing immunity through autophagy Annu. Rev. Immunol. 27 2009 423 449
154. K.D. Puri, and M.R. Gold Selective inhibitors of phosphoinositide 3-kinase delta: modulators of B-cell function with potential for treating autoimmune inflammatory diseases and B-cell malignancies Front. Immunol. 3 2012 256
155. L.C. Osborne, K.A. Duthie, J.H. Seo, R.D. Gascoyne, and N. Abraham Selective ablation of the YxxM motif of IL-7Ralpha suppresses lymphomagenesis but maintains lymphocyte development Oncogene 29 2010 3854 3864
156. R.H. Amin, and M.S. Schlissel Foxo1 directly regulates the transcription of recombination-activating genes during B cell development Nat. Immunol. 9 2008 613 622
157. H.S. Dengler, G.V. Baracho, S.A. Omori, S. Bruckner, and K.C. Arden et al. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation Nat. Immunol. 9 2008 1388 1398
158. R.C. Rickert New insights into pre-BCR and BCR signalling with relevance to B cell malignancies Nat. Rev. Immunol. 13 2013 578 591
159. C.D. Browne, C.J. Del Nagro, M.H. Cato, H.S. Dengler, and R.C. Rickert Suppression of phosphatidylinositol 3,4,5-trisphosphate production is a key determinant of B cell anergy Immunity 31 2009 749 760
160. L. Srinivasan, Y. Sasaki, D.P. Calado, B. Zhang, and J.H. Paik et al. PI3 kinase signals BCR-dependent mature B cell survival Cell 139 2009 573 586
161. F. Ramadani, D.J. Bolland, F. Garcon, J.L. Emery, and B. Vanhaesebroeck et al. The PI3K isoforms p110alpha and p110delta are essential for pre-B cell receptor signaling and B cell development Sci. Signal. 3 2010 ra60
162. M.E. Conley, A.K. Dobbs, A.M. Quintana, A. Bosompem, and Y.D. Wang et al. Agammaglobulinemia and absent B lineage cells in a patient lacking the p85alpha subunit of PI3K J. Exp. Med. 209 2012 463 470
163. C.A. Durand, K. Hartvigsen, L. Fogelstrand, S. Kim, and S. Iritani et al. Phosphoinositide 3-kinase p110 delta regulates natural antibody production, marginal zone and B-1 B cell function, and autoantibody responses J. Immunol. 183 2009 5673 5684
164. S.A. Omori, M.H. Cato, A. Anzelon-Mills, K.D. Puri, and M. Shapiro-Shelef et al. Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling Immunity 25 2006 545 557
165. Y. Aiba, M. Kameyama, T. Yamazaki, T.F. Tedder, and T. Kurosaki Regulation of B-cell development by BCAP and CD19 through their binding to phosphoinositide 3-kinase Blood 111 2008 1497 1503
166. D.A. Fruman, and G. Bismuth Fine tuning the immune response with PI3K Immunol. Rev. 228 2009 253 272
167. A. Alkhatib, M. Werner, E. Hug, S. Herzog, and C. Eschbach et al. FoxO1 induces Ikaros splicing to promote immunoglobulin gene recombination J. Exp. Med. 209 2012 395 406
168. M. Werner, E. Hobeika, and H. Jumaa Role of PI3K in the generation and survival of B cells Immunol. Rev. 237 2010 55 71
169. I. Isnardi, P. Bruhns, G. Bismuth, W.H. Fridman, and M. Daeron The SH2 domain-containing inositol 5-phosphatase SHIP1 is recruited to the intracytoplasmic domain of human FcgammaRIIB and is mandatory for negative regulation of B cell activation Immunol. Lett. 104 2006 156 165
170. S.T. Jou, N. Carpino, Y. Takahashi, R. Piekorz, and J.R. Chao et al. Essential, nonredundant role for the phosphoinositide 3-kinase p110delta in signaling by the B-cell receptor complex Mol. Cell. Biol. 22 2002 8580 8591
171. A.C. Donahue, and D.A. Fruman Proliferation and survival of activated B cells requires sustained antigen receptor engagement and phosphoinositide 3-kinase activation J. Immunol. 170 2003 5851 5860
172. T.T. Zhang, K. Okkenhaug, B.F. Nashed, K.D. Puri, and Z.A. Knight et al. Genetic or pharmaceutical blockade of p110delta phosphoinositide 3-kinase enhances IgE production J. Allergy Clin. Immunol. 122 2008 811-812.e2
173. J. Rolf, S.E. Bell, D. Kovesdi, M.L. Janas, and D.R. Soond et al. Phosphoinositide 3-kinase activity in T cells regulates the magnitude of the germinal center reaction J. Immunol. 185 2010 4042 4052
174. T.T. Zhang, K.J. Makondo, and A.J. Marshall p110delta phosphoinositide 3-kinase represses IgE switch by potentiating BCL6 expression J. Immunol. 188 2012 3700 3708
175. D.A. Fruman, and L.C. Cantley Idelalisib-a PI3Kdelta inhibitor for B-cell cancers N. Engl. J. Med. 370 2014 1061 1062
176. J.A. Burger, and K. Okkenhaug Haematological cancer: idelalisib-targeting PI3Kdelta in patients with B-cell malignancies Nat. Rev. Clin. Oncol. 11 2014 184 186
177. A.P. Kelly, D.K. Finlay, H.J. Hinton, R.G. Clarke, and E. Fiorini et al. Notch-induced T cell development requires phosphoinositide-dependent kinase 1 EMBO J. 26 2007 3441 3450
178. G.M. Delgoffe, T.P. Kole, Y. Zheng, P.E. Zarek, and K.L. Matthews et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment Immunity 30 2009 832 844
179. G.M. Delgoffe, K.N. Pollizzi, A.T. Waickman, E. Heikamp, and D.J. Meyers et al. The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2 Nat. Immunol. 12 2011 295 303
180. J. Cheng, B. Phong, D.C. Wilson, R. Hirsch, and L.P. Kane Akt fine-tunes NF-kappaB-dependent gene expression during T cell activation J. Biol. Chem. 286 2011 36076 36085
181. Y.H. Huang, and K. Sauer Lipid signaling in T-cell development and function Cold Spring Harb. Perspect. Biol. 2 2010 a002428
182. L.M. Webb, E. Vigorito, M.P. Wymann, E. Hirsch, and M. Turner Cutting edge: T cell development requires the combined activities of the p110gamma and p110delta catalytic isoforms of phosphatidylinositol 3-kinase J. Immunol. 175 2005 2783 2787
183. W. Swat, V. Montgrain, T.A. Doggett, J. Douangpanya, and K. Puri et al. Essential role of PI3Kdelta and PI3Kgamma in thymocyte survival Blood 107 2006 2415 2422
184. M.L. Janas, G. Varano, K. Gudmundsson, M. Noda, and T. Nagasawa et al. Thymic development beyond beta-selection requires phosphatidylinositol 3-kinase activation by CXCR4 J. Exp. Med. 207 2010 247 261
185. M.L. Janas, and M. Turner Interaction of Ras with p110gamma is required for thymic beta-selection in the mouse J. Immunol. 187 2011 4667 4675
186. I.X. McLeod, X. Zhou, Q.J. Li, F. Wang, and Y.W. He The class III kinase Vps34 promotes T lymphocyte survival through regulating IL-7Ralpha surface expression J. Immunol. 187 2011 5051 5061
187. K. Okkenhaug, D.T. Patton, A. Bilancio, F. Garcon, and W.C. Rowan et al. The p110delta isoform of phosphoinositide 3-kinase controls clonal expansion and differentiation of Th cells J. Immunol. 177 2006 5122 5128
188. D.R. Soond, E. Bjorgo, K. Moltu, V.Q. Dale, and D.T. Patton et al. PI3K p110delta regulates T-cell cytokine production during primary and secondary immune responses in mice and humans Blood 115 2010 2203 2213
189. Q. Wan, L. Kozhaya, A. ElHed, R. Ramesh, and T.J. Carlson et al. Cytokine signals through PI-3 kinase pathway modulate Th17 cytokine production by CCR6 + human memory T cells J. Exp. Med. 208 2011 1875 1887
190. H. Ji, F. Rintelen, C. Waltzinger, D. Bertschy Meier, and A. Bilancio et al. Inactivation of PI3Kgamma and PI3Kdelta distorts T-cell development and causes multiple organ inflammation Blood 110 2007 2940 2947
191. F. Garcon, D.T. Patton, J.L. Emery, E. Hirsch, and R. Rottapel et al. CD28 provides T-cell costimulation and enhances PI3K activity at the immune synapse independently of its capacity to interact with the p85/p110 heterodimer Blood 111 2008 1464 1471
192. N. Ladygina, S. Gottipati, K. Ngo, G. Castro, and J.Y. Ma et al. PI3Kgamma kinase activity is required for optimal T-cell activation and differentiation Eur. J. Immunol. 43 2013 3183 3196
193. M. Gigoux, J. Shang, Y. Pak, M. Xu, and J. Choe et al. Inducible costimulator promotes helper T-cell differentiation through phosphoinositide 3-kinase Proc. Natl. Acad. Sci. U. S. A. 106 2009 20371 20376
194. M.S. Thomas, J.S. Mitchell, C.C. DeNucci, A.L. Martin, and Y. Shimizu The p110gamma isoform of phosphatidylinositol 3-kinase regulates migration of effector CD4 T lymphocytes into peripheral inflammatory sites J. Leukoc. Biol. 84 2008 814 823
195. A.N. Macintyre, D. Finlay, G. Preston, L.V. Sinclair, and C.M. Waugh et al. Protein kinase B controls transcriptional programs that direct cytotoxic T cell fate but is dispensable for T cell metabolism Immunity 34 2011 224 236
196. E.M. Putz, M. Prchal-Murphy, O.A. Simma, F. Forster, and X. Koenig et al. PI3Kdelta is essential for tumor clearance mediated by cytotoxic T lymphocytes PLoS ONE 7 2012 e40852
197. A.L. Martin, M.D. Schwartz, S.C. Jameson, and Y. Shimizu Selective regulation of CD8 effector T cell migration by the p110 gamma isoform of phosphatidylinositol 3-kinase J. Immunol. 180 2008 2081 2088
198. D.R. Soond, E.C. Slack, O.A. Garden, D.T. Patton, and K. Okkenhaug Does the PI3K pathway promote or antagonize regulatory T cell development and function? Front. Immunol. 3 2012 244
199. D.T. Patton, O.A. Garden, W.P. Pearce, L.E. Clough, and C.R. Monk et al. Cutting edge: the phosphoinositide 3-kinase p110 delta is critical for the function of CD4 + CD25 + Foxp3 + regulatory T cells J. Immunol. 177 2006 6598 6602
200. Y.M. Kerdiles, E.L. Stone, D.R. Beisner, M.A. McGargill, and I.L. Ch'en et al. Foxo transcription factors control regulatory T cell development and function Immunity 33 2010 890 904
201. W. Ouyang, O. Beckett, Q. Ma, J.H. Paik, and R.A. DePinho et al. Foxo proteins cooperatively control the differentiation of Foxp3 + regulatory T cells Nat. Immunol. 11 2010 618 627
202. M.G. Strainic, E.M. Shevach, F. An, F. Lin, and M.E. Medof Absence of signaling into CD4(+) cells via C3aR and C5aR enables autoinductive TGF-beta1 signaling and induction of Foxp3(+) regulatory T cells Nat. Immunol. 14 2013 162 171
203. K. Ali, D.R. Soond, R. Pineiro, T. Hagemann, and W. Pearce et al. Inactivation of PI(3)K p110delta breaks regulatory T-cell-mediated immune tolerance to cancer Nature 510 2014 407 411
204. D. Liu, T. Zhang, A.J. Marshall, K. Okkenhaug, and B. Vanhaesebroeck et al. The p110delta isoform of phosphatidylinositol 3-kinase controls susceptibility to Leishmania major by regulating expansion and tissue homing of regulatory T cells J. Immunol. 183 2009 1921 1933
205. S.J. Shuttleworth, F.A. Silva, A.R. Cecil, C.D. Tomassi, and T.J. Hill et al. Progress in the preclinical discovery and clinical development of class I and dual class I/IV phosphoinositide 3-kinase (PI3K) inhibitors Curr. Med. Chem. 18 2011 2686 2714
206. M.P. Wymann, M. Zvelebil, and M. Laffargue Phosphoinositide 3-kinase signalling-which way to target? Trends Pharmacol. Sci. 24 2003 366 376
207. D.F. Barber, A. Bartolome, C. Hernandez, J.M. Flores, and C. Redondo et al. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus Nat. Med. 11 2005 933 935
208. M. Camps, T. Ruckle, H. Ji, V. Ardissone, and F. Rintelen et al. Blockade of PI3Kgamma suppresses joint inflammation and damage in mouse models of rheumatoid arthritis Nat. Med. 11 2005 936 943
209. S. Hayer, N. Pundt, M.A. Peters, C. Wunrau, and I. Kuhnel et al. PI3Kgamma regulates cartilage damage in chronic inflammatory arthritis FASEB J. 23 2009 4288 4298
210. L. Berod, C. Heinemann, S. Heink, A. Escher, and C. Stadelmann et al. PI3Kgamma deficiency delays the onset of experimental autoimmune encephalomyelitis and ameliorates its clinical outcome Eur. J. Immunol. 41 2011 833 844
211. A. Fougerat, S. Gayral, P. Gourdy, A. Schambourg, and T. Ruckle et al. Genetic and pharmacological targeting of phosphoinositide 3-kinase-gamma reduces atherosclerosis and favors plaque stability by modulating inflammatory processes Circulation 117 2008 1310 1317
212. T.M. Randis, K.D. Puri, H. Zhou, and T.G. Diacovo Role of PI3Kdelta and PI3Kgamma in inflammatory arthritis and tissue localization of neutrophils Eur. J. Immunol. 38 2008 1215 1224
213. S. Haylock-Jacobs, I. Comerford, M. Bunting, E. Kara, and S. Townley et al. PI3Kdelta drives the pathogenesis of experimental autoimmune encephalomyelitis by inhibiting effector T cell apoptosis and promoting Th17 differentiation J. Autoimmun. 36 2011 278 287
214. W.C. Rowan, J.L. Smith, K. Affleck, and A. Amour Targeting phosphoinositide 3-kinase delta for allergic asthma Biochem. Soc. Trans. 40 2012 240 245
215. D.G. Winkler, K.L. Faia, J.P. DiNitto, J.A. Ali, and K.F. White et al. PI3K-delta and PI3K-gamma inhibition by IPI-145 abrogates immune responses and suppresses activity in autoimmune and inflammatory disease models Chem. Biol. 20 2013 1364 1374
216. U.A. Maus, M. Backi, C. Winter, M. Srivastava, and M.K. Schwarz et al. Importance of phosphoinositide 3-kinase gamma in the host defense against pneumococcal infection Am. J. Respir. Crit. Care Med. 175 2007 958 966
217. C.L. Lucas, H.S. Kuehn, F. Zhao, J.E. Niemela, and E.K. Deenick et al. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110delta result in T cell senescence and human immunodeficiency Nat. Immunol. 15 2014 88 97
218. I. Angulo, O. Vadas, F. Garcon, E. Banham-Hall, and V. Plagnol et al. Phosphoinositide 3-kinase delta gene mutation predisposes to respiratory infection and airway damage Science 342 2013 866 871
219. M.E. Conley, and D.A. Fruman Genetics. Can cancer drugs treat immunodeficiency? Science 342 2013 814 815
220. C. Rommel, M. Camps, and H. Ji PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat. Rev. Immunol. 7 2007 191 201
221. L. Bi, I. Okabe, D.J. Bernard, A. Wynshaw-Boris, and R.L. Nussbaum Proliferative defect and embryonic lethality in mice homozygous for a deletion in the p110alpha subunit of phosphoinositide 3-kinase J. Biol. Chem. 274 1999 10963 10968
222. L.C. Foukas, M. Claret, W. Pearce, K. Okkenhaug, and S. Meek et al. Critical role for the p110alpha phosphoinositide-3-OH kinase in growth and metabolic regulation Nature 441 2006 366 370
223. M. Graupera, J. Guillermet-Guibert, L.C. Foukas, L.K. Phng, and R.J. Cain et al. Angiogenesis selectively requires the p110alpha isoform of PI3K to control endothelial cell migration Nature 453 2008 662 666
224. H. Al-Qassab, M.A. Smith, E.E. Irvine, J. Guillermet-Guibert, and M. Claret et al. Dominant role of the p110beta isoform of PI3K over p110alpha in energy homeostasis regulation by POMC and AgRP neurons Cell Metab. 10 2009 343 354
225. E. Patrucco, A. Notte, L. Barberis, G. Selvetella, and A. Maffei et al. PI3Kgamma modulates the cardiac response to chronic pressure overload by distinct kinase-dependent and -independent effects Cell 118 2004 375 387
226. T. Willinger, and R.A. Flavell Canonical autophagy dependent on the class III phosphoinositide-3 kinase Vps34 is required for naive T-cell homeostasis Proc. Natl. Acad. Sci. U. S. A. 109 2012 8670 8675
227. M. Murakami, T. Ichisaka, M. Maeda, N. Oshiro, and K. Hara et al. mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells Mol. Cell. Biol. 24 2004 6710 6718
228. Y. Wang, L. Zhang, P. Wei, H. Zhang, and C. Liu Inhibition of PI3Kdelta improves systemic lupus in mice Inflammation 37 2014 978 983
229. Y. Oka, T. Yabuuchi, T. Oi, S. Kuroda, and Y. Fujii et al. Discovery of N-{5-[3-(3-hydroxypiperidin-1-yl)-1,2,4-oxadiazol-5-yl]-4-methyl-1,3-thiazol-2-yl}acetamide (TASP0415914) as an orally potent phosphoinositide 3-kinase gamma inhibitor for the treatment of inflammatory diseases Bioorg. Med. Chem. 21 2013 7578 7583
230. F. Gonzalez-Lopez de Turiso, Y. Shin, M. Brown, M. Cardozo, and Y. Chen et al. Discovery and in vivo evaluation of dual PI3Kbeta/delta inhibitors J. Med. Chem. 55 2012 7667 7685
231. H. Li, D. Park, P.M. Abdul-Muneer, B. Xu, and H. Wang et al. PI3Kgamma inhibition alleviates symptoms and increases axon number in experimental autoimmune encephalomyelitis mice Neuroscience 253 2013 89 99
232. J.A. Marwick, G. Caramori, C.S. Stevenson, P. Casolari, and E. Jazrawi et al. Inhibition of PI3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice Am. J. Respir. Crit. Care Med. 179 2009 542 548
233. D.I. Kim, S.R. Kim, H.J. Kim, S.J. Lee, and H.B. Lee et al. PI3K-gamma inhibition ameliorates acute lung injury through regulation of IkappaBalpha/NF-kappaB pathway and innate immune responses J. Clin. Immunol. 32 2012 340 351
234. J. Azzi, R.F. Moore, W. Elyaman, M. Mounayar, and N. El Haddad et al. The novel therapeutic effect of phosphoinositide 3-kinase-gamma inhibitor AS605240 in autoimmune diabetes Diabetes 61 2012 1509 1518
235. P.C. Low, S. Manzanero, N. Mohannak, V.K. Narayana, and T.H. Nguyen et al. PI3Kdelta inhibition reduces TNF secretion and neuroinflammation in a mouse cerebral stroke model Nat. Commun. 5 2014 3450
236. X. Sun, B. Liu, R.B. Sartor, and C. Jobin Phosphatidylinositol 3-kinase-gamma signaling promotes Campylobacter jejuni-induced colitis through neutrophil recruitment in mice J. Immunol. 190 2013 357 365
237. A. Roller, A. Perino, P. Dapavo, E. Soro, and K. Okkenhaug et al. Blockade of phosphatidylinositol 3-kinase PI3Kdelta or PI3Kgamma reduces IL-17 and ameliorates imiquimod-induced psoriasis-like dermatitis J. Immunol. 189 2012 4612 4620